Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
61 | 3 | SUBSTANCE ABUSE//CANNABINOID//CANNABIS | 92118 |
851 | 2 | BUPRENORPHINE//METHADONE//INJECTION DRUG USE | 11786 |
4630 | 1 | BUPRENORPHINE//BUPRENORPHINE NALOXONE//NORBUPRENORPHINE | 1778 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | BUPRENORPHINE | authKW | 6382375 | 43% | 47% | 765 |
2 | BUPRENORPHINE NALOXONE | authKW | 727093 | 3% | 71% | 58 |
3 | NORBUPRENORPHINE | authKW | 673963 | 2% | 98% | 39 |
4 | OPIOID DEPENDENCE | authKW | 380859 | 7% | 18% | 121 |
5 | TRANSDERMAL BUPRENORPHINE | authKW | 322255 | 1% | 91% | 20 |
6 | SUBOXONE | authKW | 302444 | 1% | 74% | 23 |
7 | OPIOID RELATED DISORDERS | authKW | 244639 | 3% | 29% | 47 |
8 | EVALUAT INFORMAT PHARMACODEPENDANCE ADDICTO | address | 213420 | 1% | 71% | 17 |
9 | METHADONE | authKW | 191330 | 9% | 7% | 156 |
10 | CEIP | address | 165417 | 1% | 67% | 14 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Substance Abuse | 90579 | 33% | 1% | 594 |
2 | Psychiatry | 7206 | 24% | 0% | 418 |
3 | Pharmacology & Pharmacy | 3012 | 25% | 0% | 453 |
4 | Psychology, Clinical | 2261 | 8% | 0% | 149 |
5 | Anesthesiology | 1692 | 6% | 0% | 110 |
6 | Medicine, General & Internal | 903 | 12% | 0% | 210 |
7 | Primary Health Care | 364 | 2% | 0% | 27 |
8 | Health Care Sciences & Services | 319 | 3% | 0% | 59 |
9 | Medicine, Legal | 239 | 1% | 0% | 24 |
10 | Toxicology | 177 | 4% | 0% | 67 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EVALUAT INFORMAT PHARMACODEPENDANCE ADDICTO | 213420 | 1% | 71% | 17 |
2 | CEIP | 165417 | 1% | 67% | 14 |
3 | CEIP MARSEILLE | 124070 | 0% | 100% | 7 |
4 | SERV PHARMACOL CLIN PHARMACOVIGILANCE | 57415 | 1% | 36% | 9 |
5 | EVALUAT PHARMACODEPENDANCE ADDICTOVIGILANCE C | 56716 | 0% | 80% | 4 |
6 | EVALUAT INFORMAT PHARMACODEPENDANCE | 54273 | 0% | 44% | 7 |
7 | CEIP TOULOUSE | 53173 | 0% | 100% | 3 |
8 | PACA CORSE ASSOCIE | 53173 | 0% | 100% | 3 |
9 | SANTE PUBLEA 3279 | 53173 | 0% | 100% | 3 |
10 | PHARMACOL THER IES | 49230 | 0% | 56% | 5 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF SUBSTANCE ABUSE TREATMENT | 56385 | 5% | 4% | 88 |
2 | JOURNAL OF ADDICTION MEDICINE | 54462 | 2% | 8% | 40 |
3 | DRUG AND ALCOHOL DEPENDENCE | 53737 | 8% | 2% | 137 |
4 | AMERICAN JOURNAL ON ADDICTIONS | 36999 | 3% | 4% | 54 |
5 | HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS | 30523 | 1% | 9% | 20 |
6 | JOURNAL OF ADDICTIVE DISEASES | 24004 | 2% | 4% | 33 |
7 | SUBSTANCE ABUSE | 12281 | 1% | 4% | 17 |
8 | EUROPEAN ADDICTION RESEARCH | 12003 | 1% | 3% | 21 |
9 | THERAPIE | 11878 | 2% | 2% | 42 |
10 | ADDICTION | 11074 | 3% | 1% | 52 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUPRENORPHINE | 6382375 | 43% | 47% | 765 | Search BUPRENORPHINE | Search BUPRENORPHINE |
2 | BUPRENORPHINE NALOXONE | 727093 | 3% | 71% | 58 | Search BUPRENORPHINE+NALOXONE | Search BUPRENORPHINE+NALOXONE |
3 | NORBUPRENORPHINE | 673963 | 2% | 98% | 39 | Search NORBUPRENORPHINE | Search NORBUPRENORPHINE |
4 | OPIOID DEPENDENCE | 380859 | 7% | 18% | 121 | Search OPIOID+DEPENDENCE | Search OPIOID+DEPENDENCE |
5 | TRANSDERMAL BUPRENORPHINE | 322255 | 1% | 91% | 20 | Search TRANSDERMAL+BUPRENORPHINE | Search TRANSDERMAL+BUPRENORPHINE |
6 | SUBOXONE | 302444 | 1% | 74% | 23 | Search SUBOXONE | Search SUBOXONE |
7 | OPIOID RELATED DISORDERS | 244639 | 3% | 29% | 47 | Search OPIOID+RELATED+DISORDERS | Search OPIOID+RELATED+DISORDERS |
8 | METHADONE | 191330 | 9% | 7% | 156 | Search METHADONE | Search METHADONE |
9 | OPIATE SUBSTITUTION TREATMENT | 130557 | 1% | 39% | 19 | Search OPIATE+SUBSTITUTION+TREATMENT | Search OPIATE+SUBSTITUTION+TREATMENT |
10 | OFFICE BASED TREATMENT | 130512 | 1% | 82% | 9 | Search OFFICE+BASED+TREATMENT | Search OFFICE+BASED+TREATMENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |